November 1, 2012
November 1, 2012 —
Margarita Baggett, MSN, BSN, RN, chief nursing officer (CNO) and interim chief operating officer (COO) for UC San Diego Health System has been elected President of the Association of California Nurse Leaders (ACNL), a prestigious statewide organization that advances the art and profession of nursing.
February 20, 2019
February 20, 2019 —
UC San Diego Health is among 31 health facilities selected from across the state to participate in the California Bridge Program, an accelerated, 18-month training program for health care providers to enhance access to around-the-clock treatment for patients with opioid use disorder.
December 6, 2016
December 6, 2016 —
Patients at the newly opened Jacobs Medical Center at UC San Diego Health can be in command of their own experience by controlling room temperature, lighting, accessing their personal medical information, details on their patient care team and entertainment options all from their beds.
February 7, 2024
February 7, 2024 —
According to experts, there is a disparity between the diversity of health care staff and the patients served.
February 23, 2023
February 23, 2023 —
Get to know the rich history and future plans of new vice chancellor for Health Sciences, John M. Carethers.
October 15, 2019
October 15, 2019 —
UC San Diego bioengineers are a step closer to making CAR T-cell therapy safer, more precise and easy to control. They developed a system that allows them to select where and when CAR T cells get turned on so that they destroy cancer cells without harming normal cells.
January 18, 2018
January 18, 2018 —
…UC San Diego Health’s reputation for customizing innovative, evidenced-based care for all athletes — from the weekend warrior to elite, professional and Olympic athletes.
May 1, 2012
May 1, 2012 —
Paul S. Viviano has accepted the position as the new CEO of UC San Diego Health System and associate vice chancellor for Health Sciences. His appointment was approved by the UC Board of Regents, and will commence June 1, 2012.
September 11, 2019
September 11, 2019 —
Ventrix, a University of California San Diego spin-off company, has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack.
January 16, 2024
January 16, 2024 —
Advanced research and leading-edge tracing technology show infection prevention safety measures were effective in stopping viral spread at UC San Diego Health.